aluates Reports

$ 0.0

Automative

Global Pet Antineoplastic Drug Market Research Report 2026

Published Date: 2026-03-05

Report Code: QYRE-Auto-20L17937

Global Pet Antineoplastic Drug Market Research Report 2024

BUY CHAPTERS

Global Pet Antineoplastic Drug Market Research Report 2026

Code: QYRE-Auto-20L17937

Report

2026-03-05

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pet Antineoplastic Drug Market

The global Pet Antineoplastic Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The North American market for Pet Antineoplastic Drug is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Pet Antineoplastic Drug is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Pet Antineoplastic Drug in Mast Cell Tumor is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Pet Antineoplastic Drug include Zoetis, Merck Animal Health, Virbac, Elanco, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Pet Antineoplastic Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pet Antineoplastic Drug. The Pet Antineoplastic Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pet Antineoplastic Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pet Antineoplastic Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pet Antineoplastic Drug Market Report

Report Metric	Details
Report Name	Pet Antineoplastic Drug Market
Segment by Type	Oral Drugs Injectable Drugs
Segment by Application	Mast Cell Tumor Melanoma Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Merck Animal Health, Virbac, Elanco
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pet Antineoplastic Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pet Antineoplastic Drug Market report?

Ans: The main players in the Pet Antineoplastic Drug Market are Zoetis, Merck Animal Health, Virbac, Elanco

What are the Application segmentation covered in the Pet Antineoplastic Drug Market report?

Ans: The Applications covered in the Pet Antineoplastic Drug Market report are Mast Cell Tumor, Melanoma, Others

What are the Type segmentation covered in the Pet Antineoplastic Drug Market report?

Ans: The Types covered in the Pet Antineoplastic Drug Market report are Oral Drugs, Injectable Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Antineoplastic Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral Drugs

1.2.3 Injectable Drugs

1.3 Market by Application

1.3.1 Global Pet Antineoplastic Drug Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Mast Cell Tumor

1.3.3 Melanoma

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pet Antineoplastic Drug Market Perspective (2021–2032)

2.2 Global Pet Antineoplastic Drug Growth Trends by Region

2.2.1 Global Pet Antineoplastic Drug Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Pet Antineoplastic Drug Historic Market Size by Region (2021–2026)

2.2.3 Pet Antineoplastic Drug Forecasted Market Size by Region (2027–2032)

2.3 Pet Antineoplastic Drug Market Dynamics

2.3.1 Pet Antineoplastic Drug Industry Trends

2.3.2 Pet Antineoplastic Drug Market Drivers

2.3.3 Pet Antineoplastic Drug Market Challenges

2.3.4 Pet Antineoplastic Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pet Antineoplastic Drug Players by Revenue

3.1.1 Global Top Pet Antineoplastic Drug Players by Revenue (2021–2026)

3.1.2 Global Pet Antineoplastic Drug Revenue Market Share by Players (2021–2026)

3.2 Global Top Pet Antineoplastic Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Pet Antineoplastic Drug Revenue

3.4 Global Pet Antineoplastic Drug Market Concentration Ratio

3.4.1 Global Pet Antineoplastic Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Antineoplastic Drug Revenue in 2025

3.5 Global Key Players of Pet Antineoplastic Drug Head Offices and Areas Served

3.6 Global Key Players of Pet Antineoplastic Drug, Products and Applications

3.7 Global Key Players of Pet Antineoplastic Drug, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Pet Antineoplastic Drug Breakdown Data by Type

4.1 Global Pet Antineoplastic Drug Historic Market Size by Type (2021–2026)

4.2 Global Pet Antineoplastic Drug Forecasted Market Size by Type (2027–2032)

5 Pet Antineoplastic Drug Breakdown Data by Application

5.1 Global Pet Antineoplastic Drug Historic Market Size by Application (2021–2026)

5.2 Global Pet Antineoplastic Drug Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Pet Antineoplastic Drug Market Size (2021–2032)

6.2 North America Pet Antineoplastic Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Pet Antineoplastic Drug Market Size by Country (2021–2026)

6.4 North America Pet Antineoplastic Drug Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pet Antineoplastic Drug Market Size (2021–2032)

7.2 Europe Pet Antineoplastic Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Pet Antineoplastic Drug Market Size by Country (2021–2026)

7.4 Europe Pet Antineoplastic Drug Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pet Antineoplastic Drug Market Size (2021–2032)

8.2 Asia-Pacific Pet Antineoplastic Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Pet Antineoplastic Drug Market Size by Region (2021–2026)

8.4 Asia-Pacific Pet Antineoplastic Drug Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pet Antineoplastic Drug Market Size (2021–2032)

9.2 Latin America Pet Antineoplastic Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Pet Antineoplastic Drug Market Size by Country (2021–2026)

9.4 Latin America Pet Antineoplastic Drug Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pet Antineoplastic Drug Market Size (2021–2032)

10.2 Middle East & Africa Pet Antineoplastic Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Pet Antineoplastic Drug Market Size by Country (2021–2026)

10.4 Middle East & Africa Pet Antineoplastic Drug Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zoetis

11.1.1 Zoetis Company Details

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Pet Antineoplastic Drug Introduction

11.1.4 Zoetis Revenue in Pet Antineoplastic Drug Business (2021–2026)

11.1.5 Zoetis Recent Development

11.2 Merck Animal Health

11.2.1 Merck Animal Health Company Details

11.2.2 Merck Animal Health Business Overview

11.2.3 Merck Animal Health Pet Antineoplastic Drug Introduction

11.2.4 Merck Animal Health Revenue in Pet Antineoplastic Drug Business (2021–2026)

11.2.5 Merck Animal Health Recent Development

11.3 Virbac

11.3.1 Virbac Company Details

11.3.2 Virbac Business Overview

11.3.3 Virbac Pet Antineoplastic Drug Introduction

11.3.4 Virbac Revenue in Pet Antineoplastic Drug Business (2021–2026)

11.3.5 Virbac Recent Development

11.4 Elanco

11.4.1 Elanco Company Details

11.4.2 Elanco Business Overview

11.4.3 Elanco Pet Antineoplastic Drug Introduction

11.4.4 Elanco Revenue in Pet Antineoplastic Drug Business (2021–2026)

11.4.5 Elanco Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pet Antineoplastic Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral Drugs

Table 3. Key Players of Injectable Drugs

Table 4. Global Pet Antineoplastic Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Pet Antineoplastic Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Pet Antineoplastic Drug Market Size by Region (US$ Million), 2021–2026

Table 7. Global Pet Antineoplastic Drug Market Share by Region (2021–2026)

Table 8. Global Pet Antineoplastic Drug Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Pet Antineoplastic Drug Market Share by Region (2027–2032)

Table 10. Pet Antineoplastic Drug Market Trends

Table 11. Pet Antineoplastic Drug Market Drivers

Table 12. Pet Antineoplastic Drug Market Challenges

Table 13. Pet Antineoplastic Drug Market Restraints

Table 14. Global Pet Antineoplastic Drug Revenue by Players (US$ Million), 2021–2026

Table 15. Global Pet Antineoplastic Drug Market Share by Players (2021–2026)

Table 16. Global Top Pet Antineoplastic Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pet Antineoplastic Drug Revenue, 2025

Table 17. Ranking of Global Top Pet Antineoplastic Drug Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Pet Antineoplastic Drug Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Pet Antineoplastic Drug, Headquarters and Area Served

Table 20. Global Key Players of Pet Antineoplastic Drug, Products and Applications

Table 21. Global Key Players of Pet Antineoplastic Drug, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Pet Antineoplastic Drug Market Size by Type (US$ Million), 2021–2026

Table 24. Global Pet Antineoplastic Drug Revenue Market Share by Type (2021–2026)

Table 25. Global Pet Antineoplastic Drug Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Pet Antineoplastic Drug Revenue Market Share by Type (2027–2032)

Table 27. Global Pet Antineoplastic Drug Market Size by Application (US$ Million), 2021–2026

Table 28. Global Pet Antineoplastic Drug Revenue Market Share by Application (2021–2026)

Table 29. Global Pet Antineoplastic Drug Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Pet Antineoplastic Drug Revenue Market Share by Application (2027–2032)

Table 31. North America Pet Antineoplastic Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Pet Antineoplastic Drug Market Size by Country (US$ Million), 2021–2026

Table 33. North America Pet Antineoplastic Drug Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Pet Antineoplastic Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Pet Antineoplastic Drug Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Pet Antineoplastic Drug Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Pet Antineoplastic Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Pet Antineoplastic Drug Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Pet Antineoplastic Drug Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Pet Antineoplastic Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Pet Antineoplastic Drug Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Pet Antineoplastic Drug Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Pet Antineoplastic Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Pet Antineoplastic Drug Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Pet Antineoplastic Drug Market Size by Country (US$ Million), 2027–2032

Table 46. Zoetis Company Details

Table 47. Zoetis Business Overview

Table 48. Zoetis Pet Antineoplastic Drug Product

Table 49. Zoetis Revenue in Pet Antineoplastic Drug Business (US$ Million), 2021–2026

Table 50. Zoetis Recent Development

Table 51. Merck Animal Health Company Details

Table 52. Merck Animal Health Business Overview

Table 53. Merck Animal Health Pet Antineoplastic Drug Product

Table 54. Merck Animal Health Revenue in Pet Antineoplastic Drug Business (US$ Million), 2021–2026

Table 55. Merck Animal Health Recent Development

Table 56. Virbac Company Details

Table 57. Virbac Business Overview

Table 58. Virbac Pet Antineoplastic Drug Product

Table 59. Virbac Revenue in Pet Antineoplastic Drug Business (US$ Million), 2021–2026

Table 60. Virbac Recent Development

Table 61. Elanco Company Details

Table 62. Elanco Business Overview

Table 63. Elanco Pet Antineoplastic Drug Product

Table 64. Elanco Revenue in Pet Antineoplastic Drug Business (US$ Million), 2021–2026

Table 65. Elanco Recent Development

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

Table 69. Authors List of This Report

List of Figures

Figure 1. Pet Antineoplastic Drug Picture

Figure 2. Global Pet Antineoplastic Drug Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Pet Antineoplastic Drug Market Share by Type: 2025 vs 2032

Figure 4. Oral Drugs Features

Figure 5. Injectable Drugs Features

Figure 6. Global Pet Antineoplastic Drug Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Pet Antineoplastic Drug Market Share by Application: 2025 vs 2032

Figure 8. Mast Cell Tumor Case Studies

Figure 9. Melanoma Case Studies

Figure 10. Others Case Studies

Figure 11. Pet Antineoplastic Drug Report Years Considered

Figure 12. Global Pet Antineoplastic Drug Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Pet Antineoplastic Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Pet Antineoplastic Drug Market Share by Region: 2025 vs 2032

Figure 15. Global Pet Antineoplastic Drug Market Share by Players in 2025

Figure 16. Global Pet Antineoplastic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Pet Antineoplastic Drug Revenue in 2025

Figure 18. North America Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Pet Antineoplastic Drug Market Share by Country (2021–2032)

Figure 20. United States Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Pet Antineoplastic Drug Market Share by Country (2021–2032)

Figure 24. Germany Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Pet Antineoplastic Drug Market Share by Region (2021–2032)

Figure 32. China Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Pet Antineoplastic Drug Market Share by Country (2021–2032)

Figure 40. Mexico Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Pet Antineoplastic Drug Market Share by Country (2021–2032)

Figure 44. Israel Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Pet Antineoplastic Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Zoetis Revenue Growth Rate in Pet Antineoplastic Drug Business (2021–2026)

Figure 48. Merck Animal Health Revenue Growth Rate in Pet Antineoplastic Drug Business (2021–2026)

Figure 49. Virbac Revenue Growth Rate in Pet Antineoplastic Drug Business (2021–2026)

Figure 50. Elanco Revenue Growth Rate in Pet Antineoplastic Drug Business (2021–2026)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions